Delivery Order SPE2DB24D2003-SPE2DB24FXDK9
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENTRESTO 24 MG-26 MG tablets in 180 count bottles. The contract has a ceiling value of $15,425.32 and a performance period through April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 180S. The contract has a ceiling value of $18,282.44 and a performance period through March 26, 2024. This delivery order contract is a part of a larger, single-award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENTRESTO 97 mg-103 mg tablets. The contract has a ceiling value of $21,786.08 and a performance period through March 19, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENTRESTO 24 MG-26 MG TABLET 180S. The contract has a ceiling value of $273,064.99 and a period of performance through April 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a period of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ENTRESTO 24 MG-26 MG Tablets. The $11,416.80 contract has a performance period through March 13, 2024 and does not use a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceutical products and medical supplies to DLA Troop Support Medical,...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENTRESTO 24 mg-26 mg tablets in 180-count packages. The contract has a ceiling value of $25,396.69 and a period of performance through March 29, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under an existing $999,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a $61,266.45 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 180S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ENTRESTO 97 MG-103 MG TABLET 180S. The contract has a ceiling value of $2,384.62 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ENTRESTO 49 MG-51 MG tablets. The $2,172.17 contract has a completion date of February 1, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor for this order, which is issued under a larger indefinite delivery contract (IDC) with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product ENTRESTO 49 MG-51 MG TABLET 60S. The contract has a period of performance through March 22, 2024 and a ceiling value of $6,181.32. This delivery order contract is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB24FXDK9Delivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company, for the supply of ENTRESTO 24 MG-26 MG tablets. The contract has a ceiling value of $26,062.05 and a performance period through March 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designations have been used for these contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 3/25/24 |